Effectiveness of a thoracic multidisciplinary clinic in the treatment of stage III non-small-cell lung cancer

References

• LevitBLNassSGanzPADelivering High-Quality Cancer Care: Charting a New Course for a System in CrisisWashington, DCNational Academies Press2013
   Google Scholar
• American Society of Clinical OncologyEuropean Society for Medical Oncology. ASCO-ESMO consensus statement on quality cancer careAnn Oncol20061771063106416751232
   PubMed Web of Science ®Google Scholar
• TripathyDMultidisciplinary care for breast cancer: barriers and solutionsBreast J200391606312558678
   PubMedGoogle Scholar
• FrostMHArvizuRDJayakumarSSchoonoverANovotnyPZahaskyKA multidisciplinary healthcare delivery model for women with breast cancer: patient satisfaction and physical and psychosocial adjustmentOncol Nurs Forum199926101673168010573684
   PubMedGoogle Scholar
• HorvathLEYordanEMalhotraDMultidisciplinary care in the oncology setting: historical perspective and data from lung and gynecology multidisciplinary clinicsJ Oncol Pract201066e21e2621358946
   PubMedGoogle Scholar
• Association of Community Cancer Centers(ACCC) [webpage on the Internet]. Clinical Management and Supportive Care Services – the Multidisciplinary Team. Cancer Program Guidelines2009 Available from: http://www.accc-cancer.org/publications/CancerProgramGuidelines-4.aspAccessed February 9, 2016
   Google Scholar
• JohnsonMRClauserSBBeveridgeJMO’BrienDMTranslating scientific advances into the community setting: the National Cancer Institute Community Cancer Centers program pilotOncol Issues20092432428
   Google Scholar
• FriedmanELChawlaNMorrisPTAssessing the development of multidisciplinary care: experience of the National Cancer Institute Community Cancer Centers ProgramJ Oncol Pract20151e36e43
   Web of Science ®Google Scholar
• de CabanyesCSDetterbeckFCA systematic review of restaging after induction therapy for stage IIIa lung cancer: prediction of pathologic stageJ Thorac Oncol20105338939820186025
   PubMed Web of Science ®Google Scholar
• RamnathNDillingTJHarrisLJTreatment of stage III non-small cell lung cancer: diagnosis and management of lung cancer, 3rd edition: American College of Chest Physicians evidence-based clinical practice guidelinesChest20131435 supple314Se340S23649445
   PubMed Web of Science ®Google Scholar
• RothJAFossellaFKomakiRA randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancerJ Natl Cancer Inst19948696736808158698
   PubMed Web of Science ®Google Scholar
• DecaluwéHDe LeynPVansteenkisteJSurgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survivalEur J Cardiothorac Surg200936343343919502079
   PubMed Web of Science ®Google Scholar
• GarridoPGonzález-LarribaJLInsaALong-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901J Clin Oncol200725304736474217947721
   PubMed Web of Science ®Google Scholar
• StefaniAAlifanoMBobbioAWhich patients should be operated on after induction chemotherapy for N2 non-small cell lung cancer? Analysis of a 7-year experience in 175 patientsJ Thorac Cardiovasc Surg2010140235636320381815
   PubMed Web of Science ®Google Scholar
• YokomiseHGotohMOkamotoTInduction chemoradiotherapy (carboplatin-taxane and concurrent 60 Gy radiation) for bulky cN2, N3 non-small cell lung cancerJ Thorac Cardiovasc Surg200713351179118517467426
   PubMed Web of Science ®Google Scholar
• FriedelGBudachWDipponJPhase II Trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center studyJ Clin Oncol201028694294820100967
   PubMed Web of Science ®Google Scholar
• SuntharalingamMPaulusREdelmanMJRadiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lungInt J Radiat Oncol Biol Phys201284245646322543206
   PubMed Web of Science ®Google Scholar
• AlbainKSCrowleyJJTurrisiAT3rdConcurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019J Clin Oncol200220163454346012177106
   PubMed Web of Science ®Google Scholar
• SmithTJHillnerBEEnsuring quality cancer care by the use of clinical practice guidelines and critical pathwaysJ Clin Oncol200119112886289711387362
   PubMed Web of Science ®Google Scholar
• FriedmanESzwercMAndrewsCKruklitisRLeiesKSantiagoFNeo-adjuvant chemotherapy and radiation therapy in patients with stage IIIA (N2) non-small cell lung cancer (NSCLC): a retrospective analysis with lessons learnedPoster presented at: The 14th World Conference on Lung CancerJuly 2011Amsterdam, The Netherlands
   Google Scholar
• CaseyDEJrWhy don’t physicians (and patients) consistently follow clinical practice guidelines?JAMA Intern Med2013173171581158323897435
   PubMed Web of Science ®Google Scholar
• LeeTHCasalinoLPFisherESWilenskyGRCreating accountable care organizationsN Engl J Med201036315e2320925537
   PubMed Web of Science ®Google Scholar
• GreaneyTLAccountable care organizations – the fork in the roadN Engl J Med20113641e121175305
   PubMed Web of Science ®Google Scholar
• NeubauerMAHovermanJRKolodziejMCost effectiveness of evidence-based treatment guidelines in the treatment of non-small-cell lung cancer in the community settingJ Oncol Pract201061121820539725
   PubMedGoogle Scholar